Given that HPV E6 stimulates inactivation of p53 in tumor cells, reactivation of its expression and transduction of p53 signaling upon E6 ablation has been recommended as a putative scheme for cervical cancer therapy [153]. The gene discussed is TP53; the disease is neoplasm.